← Back to all trials
Withdrawn
NCT06329414
Acceptability and Feasibility of Transcranial Magnetic Stimulation (TMS) for Depression in Multiple Sclerosis
Conditions: Multiple Sclerosis, Major Depressive Disorder, Treatment Resistant Depression
Sex: All
Ages: 18 Years – 75 Years
Healthy volunteers: No
Sponsor: University of Utah
Location: University of Utah Health Salt Lake City Utah
Summary
The goal of this single-arm, observational pilot study is to learn about the safety, feasibility, preliminary efficacy of TMS for the treatment of depression in people with MS. Participants will receive outpatient TMS treatment over the course of 5-6 weeks. Participants will complete validated questionnaires and exams before, during, and after treatment.
Eligibility Criteria
Inclusion Criteria:
* Established diagnosis of multiple sclerosis (any subtype) by 2017 McDonald criteria
* Established diagnosis of major depressive disorder (MDD) by DSM-5 criteria
* Eligible for transcranial magnetic stimulation (rTMS) for depression
Exclusion Criteria:
* MS relapse and/or steroid use within 3 months
* Active suicidal ideation
* History of seizure/epilepsy, brain tumor, or stroke
* History of bipolar disorder or psychosis
* Currently or planning to become pregnant
Source: ClinicalTrials.gov (NCT06329414). StuddyBuddy aggregates publicly available trial information.